169 related articles for article (PubMed ID: 31943232)
41. Poor prognostic subgroup in T3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy.
Imamura T; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
J Surg Oncol; 2015 Feb; 111(2):221-5. PubMed ID: 25327711
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
[TBL] [Abstract][Full Text] [Related]
43. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
[TBL] [Abstract][Full Text] [Related]
44. Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
Gong L; Zhang JW; Yin RT; Wang P; Liu H; Zheng Y; Lou JY; Peng ZL
Int J Gynecol Cancer; 2016 May; 26(4):722-8. PubMed ID: 26905330
[TBL] [Abstract][Full Text] [Related]
45. Blast from the past: Perioperative use of the Maruyama computer program for prediction of lymph node involvement in the surgical treatment of gastric cancer following neoadjuvant chemotherapy.
Rawicz-Pruszyński K; Mielko J; Ciseł B; Skórzewska M; Pikuła A; Gęca K; Skoczylas T; Kubiatowski T; Kurylcio A; Polkowski WP
Eur J Surg Oncol; 2019 Oct; 45(10):1957-1963. PubMed ID: 31178298
[TBL] [Abstract][Full Text] [Related]
46. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
[TBL] [Abstract][Full Text] [Related]
47. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy.
Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J
Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
49. The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.
Picado O; Dygert L; Macedo FI; Franceschi D; Sleeman D; Livingstone AS; Merchant N; Yakoub D
J Surg Res; 2018 Dec; 232():422-429. PubMed ID: 30463751
[TBL] [Abstract][Full Text] [Related]
50. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
Martin-Romano P; Sola JJ; Diaz-Gonzalez JA; Chopitea A; Iragorri Y; Martínez-Regueira F; Ponz-Sarvise M; Arbea L; Subtil JC; Cano D; Ceniceros L; Legaspi J; Hernandez JL; Rodríguez J
Br J Cancer; 2016 Sep; 115(6):655-63. PubMed ID: 27537382
[TBL] [Abstract][Full Text] [Related]
51. Short- and Long-Term Outcomes in Malnourished Patients After Laparoscopic or Open Radical Gastrectomy.
Zheng HL; Lu J; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Tu RH; Huang CM
World J Surg; 2018 Jan; 42(1):195-203. PubMed ID: 28741200
[TBL] [Abstract][Full Text] [Related]
52. Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis.
Singh B; Fisher OM; Singh G; Lansom J; Bock M; Kozman M; Alzahrani N; Liauw W; Morris DL
Ann Surg Oncol; 2019 Oct; 26(11):3627-3635. PubMed ID: 31292804
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value and clinicopathological correlation of the tumor regression grade in neoadjuvant chemotherapy for gastric adenocarcinoma: a retrospective cohort study.
Wang Y; Xu H; Hu C; Yu P; Bao Z; Zhang Y; Zhang R; Zhang S; Li B; Aerts JM; Xu Z; Cheng X
J Gastrointest Oncol; 2022 Jun; 13(3):1046-1057. PubMed ID: 35837180
[TBL] [Abstract][Full Text] [Related]
54. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
[TBL] [Abstract][Full Text] [Related]
55. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.
Greenleaf EK; Hollenbeak CS; Wong J
Surgery; 2016 Apr; 159(4):1099-112. PubMed ID: 26704785
[TBL] [Abstract][Full Text] [Related]
56. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer.
Behtash N; Nazari Z; Ayatollahi H; Modarres M; Ghaemmaghami F; Mousavi A
Eur J Surg Oncol; 2006 Dec; 32(10):1226-30. PubMed ID: 16952434
[TBL] [Abstract][Full Text] [Related]
57. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification.
Wei J; Yao T; Wang Y; Li L; Pan C; Zhang N
Clin Transl Oncol; 2019 Feb; 21(2):232-238. PubMed ID: 29968135
[TBL] [Abstract][Full Text] [Related]
58. Impact of interval timing to surgery on tumor response after neoadjuvant treatment for gastric cancer.
Ocaña Jiménez J; Priego P; Cuadrado M; Blázquez LA; Sánchez Picot S; Pastor Peinado P; Longo F; López F; Caminoa-Lizarralde MA; Galindo J
Rev Esp Enferm Dig; 2020 Aug; 112(8):598-604. PubMed ID: 32496120
[TBL] [Abstract][Full Text] [Related]
59. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
60. Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case-Control Study.
Kelly KJ; Selby L; Chou JF; Dukleska K; Capanu M; Coit DG; Brennan MF; Strong VE
Ann Surg Oncol; 2015 Oct; 22(11):3590-6. PubMed ID: 25631063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]